section name header

Y-Site Injection Compatibility (1:1 Mixture)

Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mLb)

I

Heparin sodium

(Mfr: PAN)(Conc: 192.3 units/mLb)

Remarks:

Persistent particulate formation

Ref:

3405,3417